Postbiotic Prowess: ADM’s ES1 Postbiotic Wins Immune & Gut Health Ingredient Category at Inaugural Vitafoods Europe Innovation Awards
ADM's innovative heat-treated postbiotic* Bifidobacterium longum CECT 7347 (HT-ES1**) has won the Immune and Gut Health Ingredient category at the 2025 Vitafoods Europe Innovation Awards.
In its inaugural year, the Vitafoods Europe Innovation Awards' goal is to recognize the outstanding ingredients, products, partnerships and initiatives redefining the nutraceutical landscape. The judging panel deemed ADM's ES1 postbiotic as a game-changer for immune and gut health. Additionally, the newest addition to ADM’s solutions library, Lactobacillus gasseri CP2305 postbiotic, was highly commended in the Cognitive and Emotional Health Ingredient category.
"This win represents ADM's ongoing commitment to science-backed innovation through robust research into the gut microbiome," said Marie-Bénédicte Charpentier, Marketing Director, Head of EMEA, ADM. "Vitafoods Europe brings together significant leaders in the industry, and we're honored to be recognized among them with our ES1 postbiotic at the inaugural innovation awards."
"ES1 postbiotic is a gold-standard example of the gut microbiome-supporting solutions within our portfolio, with clinical trials demonstrating its support for gut health and analysis reinforcing the link between the gut microbiome and different aspects of well-being," continued Charpentier.
A 2024 clinical study published in the prestigious journal Gut Microbes indicates that the award-winning ES1 postbiotic may support overall gut and digestive health, in addition to the potential of supporting reduced bloating1. The randomized, double-blind placebo controlled human clinical trial on adults with IBS-D showed strong and consistent results for ES1 postbiotic supplementation, including clinically meaningful improvements in IBS-Symptom Severity Scale (IBS-SSS) scores and quality of life, compared to placebo1.
"Postbiotics are incredibly resilient, retaining efficacy through virtually any formulation environment, from high heat to high water content and more," said Charpentier. “As such, postbiotics like ES1 and L. gasseri CP2305 are posed to pave the way for what's next in health and wellness product development, bringing forward new and expanded offerings in functional foods, beverages and dietary supplements that can easily fit into consumers' daily routines, helping them reach their wellness goals."
ES1 has received recognition in both pro- and postbiotic forms at several industry awards:
• At the 2024 Fi Europe Innovation Awards, ES1 postbiotic was named the Health Innovation category winner.
• ES1 postbiotic was a finalist for the Best Health Innovation Award in the 2024 World Food Innovation Awards, organized by FoodBev Media.
• At the 2023 Gulfood Manufacturing Industry Excellence Awards, ES1 probiotic and ES1 postbiotic won the Best Ingredients Innovation Award.
Learn more about ADM's award-winning microbiome solutions and capabilities here.
References
1Srivastava, S., et al. (2024) Gut Microbes. 16(1):2338322
*Please note that in the EU, the terms 'prebiotic' and 'postbiotic' are not permitted for use in finished products intended for final consumers, and the term 'probiotic' is only allowed in certain countries. Therefore, alternative wording should be used in finished product artwork. It is the responsibility of the finished product manufacturer to ensure that all statements on the artwork comply with current regulations.
**Bifidobacterium longum CECT7347 (ES1) is used by ADM Biopolis under license from CSIC.